Bio-Behavioral Lung Cancer Prevention Program
Interventional
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment
Continuous abstinence: measured at end of treatment and at 6- and 12- months after cessation.
Caryn Lerman
Principal Investigator
University of Pennsylvania
United States: Federal Government
703463
NCT00322205
June 1999
March 2002
Name | Location |
---|---|
State University of New York | Buffalo, New York 14203-1154 |